Exchange Surveillance
No active ASM or GSM measures on this stock.
Price band ± 20%
Price
Trading Data
range barsReturns
absolute and vs benchmark indexAbout the Company
Astec Lifesciences Ltd has over two decades of experience in the chemical industry.The company employs highly qualified and trained personnel to monitor and maintain its manufacturing activities as well as process development work. A strong R&D focus has enabled the company to introduce a number of unique products.Their product range includes Tebuconazole, Hexaconazole,Propiconazole, Metalaxyl,Pentanediol, Dicap ,Fluoro & phenacyl chloride.
- Sector
- Basic Materials
- Industry
- Agricultural Inputs
- HQ
- Mumbai, Maharashtra
- Chairman
- Nadir B Godrej
- CEO & MD
- Ashok V Hiremath
- Registrar
- Bigshare Services Pvt. Ltd.
- Exchange
- NSE
- ISIN
- INE563J01010
Institutional Demand
passive ownership through ETFsContext
where this company sitsFrequently Asked
▶What is the share price of Astec Lifesciences Ltd today?
Astec Lifesciences Ltd (ASTEC) is trading at ₹663.7. The price shown is the latest available from the exchange feed and updates through the trading session.
▶What is ASTEC’s P/E ratio versus the sector?
ASTEC trades at a P/E of —. Its industry median is shown alongside it in Key Stats, so you can see at a glance whether the stock is priced above or below the businesses it competes with. A lower P/E is not automatically cheaper — it can also reflect slower expected growth.
▶What is ASTEC’s dividend yield?
ASTEC has a dividend yield of 0.00%, based on dividends declared over the last twelve months against the current price. The full dividend history is on the News & Filings tab.
▶What is ASTEC’s 52-week high and low?
ASTEC has traded between ₹513.4 and ₹941.75 over the past year. The Trading Data block shows where the current price sits inside that band.
▶What is the market capitalisation of Astec Lifesciences Ltd?
Astec Lifesciences Ltd has a market capitalisation of ₹1,625 crore.
▶What is ASTEC’s return on equity?
ASTEC reports a return on equity of -25.3%. ROE measures profit generated per rupee of shareholder capital, and is most meaningful compared against others in Agricultural Inputs.
▶Who are ASTEC’s competitors?
The Peers block on this page lists other Agricultural Inputs companies with their price, P/E and market capitalisation. The Valuation tab compares multiples against the industry median in more depth.
▶What is ASTEC’s promoter holding?
Promoters hold 71.97% of ASTEC. The Ownership tab shows the full shareholding pattern — promoter, FII, DII and public — and how each has moved across recent quarters.
▶Which indices include ASTEC?
Index membership is listed in the Context block on this page, along with the weight ASTEC carries in each. That weight is what determines how much passive money tracks the stock.
▶Is Astec Lifesciences Ltd a good buy?
We do not publish buy or sell calls. What this page gives you instead is the evidence: our Value & Investment Index for where the price sits against its own history, the Fundamental Strength Index for the quality of the business, an investment checklist of criteria applied to every stock, and pros and cons generated from ASTEC’s own numbers. The judgement is yours.
ASTEC at a glance
Astec Lifesciences Ltd operates in the Agricultural Inputs industry, part of the Basic Materials sector. Astec Lifesciences Ltd (ASTEC) last traded at ₹663.7, giving it a market capitalisation of ₹1,625 crore. The 52-week range is ₹513.4 to ₹941.75, and the price is 35% of the way up that range. Promoters hold 71.97% of the company in the latest shareholding filing.
| Market cap | ₹1,625 crore |
|---|---|
| ROE | -25.3% |
| ROCE | -5.5% |